¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ´ç´¢º´ÇÐȸ 2022 International Congress of Diabetes and Metabolism(3ÀÏÂ÷) : 2022-10-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ´ç´¢º´ÇÐȸ 2022 International Congress of Diabetes and Metabolism(3ÀÏÂ÷) : 2022-10-08
±³À°ÀÏÀÚ : 2022-10-08
±³À°Àå¼Ò : ½ºÀ§½º±×·£µåÈ£ÅÚ  
±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà) 2022 International Congress of Diabetes and Metabolism(3ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ 
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071  
À̸ÞÀÏ : diabetes@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 430,000¿ø      
ºñ°í »çÀü: ¿ÀÇÁ¶óÀÎ-ÀÇ»ç ȸ¿ø:25¸¸¿ø »çÀü: ¿ÀÇÁ¶óÀÎ-ÀÇ»ç ºñȸ¿ø:32¸¸¿ø »çÀü: ¿ÀÇÁ¶óÀÎ-ºñÀÇ»ç ȸ¿ø:15¸¸¿ø »çÀü: ¿ÀÇÁ¶óÀÎ-ºñÀÇ»ç ºñȸ¿ø:20¸¸¿ø »çÀü: ¿Â¶óÀÎ-ÀÇ»ç ȸ¿ø:20¸¸¿ø »çÀü: ¿Â¶óÀÎ-ÀÇ»ç ºñȸ¿ø:27¸¸¿ø »çÀü: ¿Â¶óÀÎ-ºñÀÇ»ç ȸ¿ø:10¸¸¿ø »çÀü: ¿Â¶óÀÎ-ºñÀÇ»ç ºñȸ¿ø:15¸¸¿ø ÇöÀå: ¿ÀÇÁ¶óÀÎ-ÀÇ»ç ȸ¿ø:35¸¸¿ø ÇöÀå: ¿ÀÇÁ¶óÀÎ-ÀÇ»ç ºñȸ¿ø:43¸¸¿ø ÇöÀå: ¿ÀÇÁ¶óÀÎ-ºñÀÇ»ç ȸ¿ø:20¸¸¿ø ÇöÀå: ¿ÀÇÁ¶óÀÎ-ºñÀÇ»ç ºñȸ¿ø:25¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 09:00~09:30 Diagnosis of classic type 1 diabetes and LADA  Sang-Man Jin(Sungkyunkwan University Korea) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 09:30~10:00 Update on CGM and connected insulin pens in type 1 diabetes  Jee Hee Yoo(Yonsei Wonju University Korea) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 10:00~10:30 Highlights from the international consensus meeting on recommendations for the use of Automated Insulin Delivery (AID) technologies in clinical practice  Revital Nimri(Schneider Children¡¯s Medical Center of Israel Israel) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 10:30~11:00 Adjunctive therapy in type 1 diabetes (metformin, GLP-1RA, SGLT2i)  Jae Hyun Bae(Korea University Korea) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 11:20~12:00 Preventing type 2 diabetes: back to the future  Vanita R. Aroda(Brigham and Women¡¯s Hospital Harvard Medical School USA) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 12:20~13:30 Optimal clinical approach for the management of diabetes and chronic complications with SGLT2-inhibitor  Mark Cooper(Monash University Australia) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 13:30~14:00 Renal Benefit of Tirzepatide  Hiddo Lambers Heerspink(University Medical Center Groningen Netherlands) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 14:00~14:30 Cag-Sema combination  Jaehan Jeon(Kyungpook National University Korea) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 14:30~15:00 When they go low, we go high _ GLP-1/Glucagon Dual Agonisttide  Seungjae Baek(Hanmi Pharmaceutical Korea) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 15:00~15:30 The novel GIP, GLP-1, and glucagon triple receptor agonist LY3437943: From discovery to clinical proof-of-concept  Tamer Coskun(Eli Lilly and Company USA) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 15:30~16:00 EASD/ESC Symposium: new perspectives on heart function and failure in diabetes  Javed Butler(University of Mississippi USA) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 16:00~16:30 New insights to prevention of microvascular complications?  Christoph Wanner(University Hospital Wuerzburg Germany) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ´ç´¢º´ÇÐȸ 2022 International Congress of Diabetes and Metabolism(3ÀÏÂ÷) : 2022-10-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022 ´ëÇÑ°ñ´Ù°øÁõÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2022-10-09
´ÙÀ½±Û (¿Â¶óÀÎ) 2022³âµµ Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤: Á¤½ÅºÐ¼®Àû Ä¡·áÀÇ ÁÖ¿ä °³³äµé°ú ÀÓ»óÀû È°¿ë 2 : 2022-10-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21152 ºÎ»ê ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ¿µ³²Áöȸ ÇÏ°èÁý´ãȸ : 2024-07-11 0 2 2024-07-01
21151 ºÎ»ê ´ëÇѺñ´¢ÀÇÇÐȸ 311ȸ Çмú´ëȸ(Àü¸³¼± ¾Ï) : 2024-07-11 0 4 2024-07-01
21150 ºÎ»ê ´ëÇÑ°£ÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ : 2024-07-11 0 4 2024-07-01
21149 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ (¿Â¶óÀÎ) KSMO 7¿ù ºÐ±âÁý´ãȸ : 2024-07-11 0 1 2024-07-01
21148 ÀÎõ Çѱ¹¿©ÀÚÀÇ»çȸ ÀÎõÁöȸ 7¿ù Çмú½ÉÆ÷Áö¾ö(Ä¡¸Å) : 2024-07-10 0 2 2024-07-01
21147 ¼­¿ï Á¦137ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ Áý´ãȸ : 2024-07-10 0 9 2024-07-01
21146 ¿ï»ê ¿ï»ê À̺ñÀÎÈÄ°ú Çмú ¼¼¹Ì³ª : 2024-07-09 0 3 2024-07-01
21145 ´ëÀü ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ´ëÀüÃæûÁöȸ 7¿ù ¿¬¼ö°­Á : 2024-07-09 0 2 2024-07-01
21144 ¼­¿ï 2024 ´ëÇÑ»êºÎÀΰú³»ºÐºñÇÐȸ Á¦33Â÷ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-07-07 0 2 2024-07-01
21143 ´ëÀü 2024 ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ´ëÀüÃæûÁöȸ ¿¬¼ö°­Á : 2024-07-07 0 4 2024-07-01
21142 ¼­¿ï 2024³â Á¦11ȸ ´ëÇѳ²¼º°úÇÐȸ-´ëÇѺñ´¢ÀÇÇаúÀÇ»çȸ °øµ¿½ÉÆ÷Áö¾ö : 2024-07-07 0 1 2024-07-01
21141 ¿ï»ê ¿ï»ê´ëÇб³º´¿ø ½Å°æ¿Ü°ú ½ÉÆ÷Áö¿ò : 2024-07-06 0 3 2024-07-01
21140 ´ë±¸ Á¦7ȸ °æºÏ´ëÇб³ ¾È°úÇб³½Ç ½ÉÆ÷Áö¾ö : 2024-07-06 0 2 2024-07-01
21139 ¼­¿ï 2024 ´ëÇѵΰæºÎ¿Ü°úÇÐȸ ÃÊÀ½ÆÄ ¿öÅ©¼ó : 2024-07-06 0 2 2024-07-01
21138 ±¤ÁÖ 2024 Àü³²´ëÇб³º´¿ø Á¤½Å°Ç°­ÀÇÇаú ±¹Á¦½ÉÆ÷Áö¾ö : 2024-07-05 0 1 2024-07-01
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷